Exicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements
About Exicure
Exicure, Inc. has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. Following its recent restructuring and suspension of clinical and development activities, the Company is exploring strategic alternatives to maximize stockholder value, both with respect to its historical biotechnology assets and more broadly. For further information, see www.exicuretx.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Brook + Whittle Secures $130 Million of New Financing
Transaction extends maturities and provides new capital to invest in operational excellence and growth strategy GUILFORD, Conn., August 11, 2025--(BUSINESS WIRE)--Brook + Whittle (the "Company"), a leader in sustainable packaging solutions, today announced the successful completion of a refinancing transaction. As a part of the transaction, the Company secured $130 million in new capital, established a new revolving credit facility, and extended its debt maturity runway, providing the Company with additional liquidity to accelerate investments in growth and sustainability initiatives. "The successful completion of this transaction underscores the confidence our capital partners have in our team and strategy, providing the Company with the capital and financial flexibility needed to navigate the current market, deepen our investments in sustainability, execute our value creation strategy, and continue delivering best-in-class packaging solutions to our customers," said Mark Pollard, Chief Executive Officer. "We are grateful for the strong support of our stakeholders and look forward to our future success as we focus on our growth strategy, further enhancing our capabilities and product offerings." Brook + Whittle is committed to offering best-in-class labeling solutions while empowering brands with the tools and education necessary to transition to more sustainable alternatives. With this financing, the Company is well-positioned to continue its near and long-term growth strategies. About Brook + WhittleBrook + Whittle is one of North America's leading manufacturers of pressure-sensitive, shrink sleeves, flexible packaging, and heat transfer labels. The Company operates fourteen locations across the US and delivers value to customers through sustainable packaging, complex decoration, digitalization, and industry leading lead-times. To learn more about Brook + Whittle, visit View source version on Contacts Brook + Whittle Marketingmarketing@ C Street Advisory Groupbrook-whittle@ Sign in to access your portfolio
Yahoo
23 minutes ago
- Yahoo
AI Hedge Funds Surge As Billions Flow
Nvidia (NASDAQ:NVDA) mania is spilling into hedge funds, with new AI focused managers raising billions and posting eye catching gains, The Wall Street Journal reported. Leopold Aschenbrenner's Situational Awareness has topped $1.5 billion in assets and returned 47% in the first half, versus 6% for the S&P 500 (SP500). His pitch is simple: buy likely AI winners in semiconductors and infrastructure, hedge with shorts in weaker pockets. Warning! GuruFocus has detected 5 Warning Signs with NVDA. Backers include high profile tech names. The wave is bigger than one fund. Value Aligned Research Advisors launched in March, quickly reached $1 billion and is also running $2 billion across AI strategies. Point72 backed Turion, which now sits above $2 billion. Crowding is the catch. Many funds cluster in the same names. Vistra (NYSE:VST), a key power supplier to data centers, showed up as a shared favorite as of March. And the same momentum that boosts early returns can cut the other way when AI stocks wobble. money is following the AI build out, but concentration and volatility make risk control as important as stock picking. Flows and performance will get a fresh read with the next 13F filings and big AI earnings on deck. This article first appeared on GuruFocus.
Associated Press
24 minutes ago
- Associated Press
Law Offices of Frank R. Cruz Encourages Lineage, Inc. (LINE) Investors to Inquire About Securities Fraud Class Action
LOS ANGELES--(BUSINESS WIRE)--Aug 11, 2025-- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Lineage, Inc. ('Lineage' or the 'Company') (NASDAQ: LINE ) common stock pursuant and/or traceable to the registration statement used in connection with the Company's July 2024 initial public offering (the 'IPO'). Lineage investors have until September 30, 2025 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS ON YOUR LINEAGE, INC. (LINE) INVESTMENTS, CLICKHERETO SUBMIT A CLAIM TO POTENTIALLY RECOVER YOUR LOSSES IN THE ONGOING SECURITIES FRAUD LAWSUIT. You can also contact the Law Offices of Frank R. Cruz to discuss your legal rights by email at [email protected], by telephone at (310) 914-5007, or visit our website at What Happened? In July 2024, Lineage conducted its IPO, selling over 65 million shares of common stock at $78 per share. On November 6, 2024, Lineage released its third quarter 2024 financial results, revealing that it had suffered a $543 million net loss during the quarter. On this news, Lineage's stock price fell $5.22, or 7.4%, to close at $65.79 per share on November 6, 2024, thereby injuring investors. Then, on January 14, 2025, The Wall Street Journal reported that Lineage was laying off employees due to reduced customer demand only six months after its IPO. Then, on April 7, 2025, Lineage announced the dismissal of its auditor, KPMG LLP. On this news, Lineage's stock price fell $5.29, or 9.9%, over two consecutive trading days, to close at $48.41 per share on April 8, 2025. Then, on April 30, 2025, Lineage reported first quarter 2025 financial results, including that '[t]otal revenue decreased (2.7)%' to $1.29 billion for the quarter. The Company stated it 'experienced more normal seasonal trends in the first quarter after multiple years of elevated inventory levels.' On this news, Lineage's stock price fell $8.16, or 14.62%, to close at $47.65 per share on April 30, 2025, thereby injuring investors further. On June 3, 2025, the Company stated at an Investor Conference that there has been 'pretty much flat demand' for Lineage's products and services and that the Company was operating in a 'flattish environment' in terms of demand. The price of Lineage stock has remained substantially below the IPO price at the time of this complaint's filing. What Is The Lawsuit About? The complaint filed in this class action alleges that the Registration Statement made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Lineage was then experiencing sustained weakening in customer demand, as additional cold-storage supply had come on line, the Company's customers destocked a glut of excessive inventory built up during the COVID-19 pandemic, and the Company's customers shifted to maintaining leaner cold-storage inventories on a go-forward basis in response to changed consumer trends; (2) that Lineage had implemented price increases in the lead-up to the IPO that could not be sustained in light of the weakening demand environment facing the Company; (3) that Lineage was unable to effectively counteract the adverse trends listed in the foregoing through the use of minimum storage guarantees or as a result of operational efficiencies, technological improvements, or its purported competitive advantages; (4) that, as a result of the foregoing, rather than enjoying stable revenue growth, high occupancy rates, and steady rent escalation as represented in the Registration Statement, Lineage was in fact suffering from stagnant or falling revenue, occupancy rates, and rent prices; and (5) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. Contact Us To Participate or Learn More: If you purchased Lineage common stock, wish to learn more about this action, or have any questions concerning this announcement or your rights or interests with respect to these matters, please click HERE or contact us at: Law Offices of Frank R. Cruz 2121 Avenue of the Stars, Suite 800 Telephone: 310-914-5007 Email: [email protected] Visit our website at: This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. View source version on CONTACT: Law Offices of Frank R. Cruz 2121 Avenue of the Stars, Suite 800 Telephone: 310-914-5007 Email:[email protected] Visit our website at: KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL SOURCE: The Law Offices of Frank R. Cruz Copyright Business Wire 2025. PUB: 08/11/2025 12:06 PM/DISC: 08/11/2025 12:07 PM
